secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001641172-25-010964
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CSO and VP Regulatory resign; shareholders authorize reverse split and large issuances
--------------------------------------------------------------------------------

- Dr. Anatoly Dritschilo resigned as CSO and director effective May 9, 2025; no disagreement cited.
- Michael P. Vander Hoek resigned as VP Regulatory effective June 10, 2025; no disagreement cited.
- Shareholders approved reverse stock split at ratio from 1-for-3 to 1-for-100.
- Approved increase in equity plan shares by 5,000,000 and issuances of >19.99% stock on note conversion.
- Approved issuances of >20% stock on convertible preferred offering and equity line of credit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225010964/0001641172-25-010964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225010964/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-010964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer